Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Basedow's disease
ADR ID BADD_A00427
ADR Hierarchy
05      Endocrine disorders
05.02      Thyroid gland disorders
05.02.02      Thyroid hyperfunction disorders
05.02.02.003      Basedow's disease
06      Eye disorders
06.09      Ocular structural change, deposit and degeneration NEC
06.09.04      Structural change, deposit and degeneration of eye NEC
06.09.04.003      Basedow's disease
10      Immune system disorders
10.04      Autoimmune disorders
10.04.08      Endocrine autoimmune disorders
10.04.08.004      Basedow's disease
Description A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). [MeSH]
MedDRA Code 10004161
MeSH ID D006111; D006111; D006111
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Basedow's disease | Disease Graves' | Exophthalmic goiter | Exophthalmic goitre | Goiter exophthalmic | Graves' disease | Toxic diffuse goiter | Toxic diffuse goiter without mention of thyrotoxic crisis or storm | Toxic diffuse goitre | Graves-Basedow disease | Autoimmune hyperthyroidism | Goitre exophthalmic | Graves Disease | Disease, Graves | Basedow Disease | Disease, Basedow | Graves' Disease | Disease, Graves' | Exophthalmic Goiter | Exophthalmic Goiters | Goiters, Exophthalmic | Goiter, Exophthalmic | Hyperthyroidism, Autoimmune | Basedow's Disease | Basedows Disease | Disease, Basedow's
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00008Abacavir--
BADD_D00064Alemtuzumab--
BADD_D00066Alendronic acid0.000303%
BADD_D00115Amiodarone0.001488%
BADD_D00165Aripiprazole0.000381%
BADD_D00176Atazanavir--
BADD_D00285Bosentan0.000447%
BADD_D00586Darunavir--
BADD_D00704Dolutegravir sodium--
BADD_D00708Dopamine0.000371%
BADD_D00749Efavirenz--
BADD_D00757Eliglustat0.021361%
BADD_D00762Elvitegravir--
BADD_D00766Emtricitabine--
BADD_D00788Epoprostenol0.003153%
BADD_D00809Escitalopram0.000095%
BADD_D00857Etravirine--
BADD_D00961Fosamprenavir calcium--
BADD_D00981Gabapentin0.000051%
BADD_D01023Glimepiride0.000191%
BADD_D01136Imatinib0.000533%
BADD_D01150Indinavir--
BADD_D01213Isotretinoin0.001263%
BADD_D01242Lamivudine--
BADD_D01253Lenalidomide--
BADD_D01281Levonorgestrel0.004169%
BADD_D01285Levothyroxine0.000092%
BADD_D01286Levothyroxine sodium--
BADD_D01352Maraviroc--
BADD_D01414Methimazole0.001083%
The 1th Page    1 2    Next   Last    Total 2 Pages